A biologically based dose-response (BBDR) model for the hypothalamic-pituitary thyroid (HPT) axis in the lactating rat and nursing pup was developed to describe the perturbations caused by iodide deficiency on the HPT axis. Model calibrations, carried out by adjusting key model parameters, were used as a technique to evaluate HPT axis adaptations to dietary iodide intake in euthyroid (4.1-39 µg iodide/day) and iodide-deficient (0.31 and 1.2 µg iodide/day) conditions. Iodide-deficient conditions in both the dam and the pup were described with increased blood flow to the thyroid gland, TSH-mediated increase in thyroidal uptake of iodide and binding of iodide in the thyroid gland (organification), and, in general, reduced thyroid hormone production and metabolism. Alterations in thyroxine (T4) homeostasis were more apparent than for triiodothyronine (T3). Model-predicted average daily area-under-the-serum-concentration-curve (nM-day) values for T4 at steady state in the dam and pup decreased by 14-15% for the 1.2 µg iodide/day iodide-deficient diet and 42-52% for the 0.31 µg iodide/day iodide-deficient diet. In rat pups that were iodide deficient during gestation and lactation, these decreases in serum T4 levels were associated with declines in thyroid hormone in the fetal brain and a suppression of synaptic responses in the hippocampal region of the brain of the adult offspring (Gilbert et al., 2013) .
It is well established that adequate levels of thyroid hormone are essential for normal brain development (Gilbert and Zoeller, 2010) . Xenobiotic-induced changes in the hypothalamicpituitary thyroid (HPT) axis in rodents, using common measurements, such as serum thyroid hormones and thyroid stimulating hormone (TSH), are difficult to interpret for human health significance. This difficulty arises, in part, because of considerable species differences in the biology of the HPT axis and the lack of information on the degree of thyroid hormone disruption required to impact neurodevelopment (Fisher et al., 2012) . Biologically based dose-response models for the HPT axis are computational tools that can assist in dose-response analysis for thyroid-active chemicals in laboratory animals and in extrapolation of rodent HPT perturbations to humans. BBDR-HPT axis models also provide a place from which to begin to define the relationships between serum thyroid hormones and adverse outcomes. Rodent BBDR-HPT axis models have been recently developed in the adult Sprague Dawley and Long Evans rats (Gilbert et al., 2011; McLanahan et al., 2008) to better understand alterations in the HPT axis caused by dietary iodide deficiency and by ingestion of perchlorate, a thyroid-active environmental and food contaminant (McLanahan et al., 2009) . The fetus, infant, and child are thought to be the most sensitive to alterations in serum thyroid hormone levels because of the risks of irreversible developmental neurotoxicity (Zoeller, 2007) . Thus, the BBDR-HPT axis models were extended to the developmental phases of life for the Long Evans rat using data reported in a companion article (Gilbert et al., 2013) . Pedraza et al., (2008) concluded from experimental studies with several dietary iodide intake rates in adult rats, ranging from severe deficiency (0.02 µg iodide/day) to adequate iodide intake (5 µg iodide/day), that iodide intakedependent adaptations occur. These adaptations depend on the degree of iodide deficiency, whereas others may occur by TSH-independent mechanisms. These authors further demonstrated that the adequacy of such adaptive mechanisms is largely organ specific and may be regionally specific within the brain. In this article, a BBDR-HPT axis model for the lactating Long Evans dam and nursing pup on post natal day (PND) 14 is presented for dietary iodide-deficient and -sufficient conditions. Model calibrations, carried out by adjusting key model parameters, were used as a technique to evaluate HPT axis adaptations to dietary iodide intake in the euthyroid (4.1-39 µg iodide/day) and iodide-deficient (0.31 and 1.2 µg iodide /day) states. Euthyroid conditions in the lactating dam were determined based on previous iodide intake studies in the euthyroid lactating dam and pup (5-10 µg iodide/day; Obregón et al., 1991) , whereas iodide-deficient conditions were based on studies in adult (Pedraza et al., 2006) and lactating rats (Escobar del Rey et al., 1987; Obregón et al., 1991) and previous BBDR-HPT axis modeling studies in the adult rat (Gilbert et al., 2011; McLanahan et al., 2008) .
MATeRIAlS AnD MeTHoDS
The details of the study design and neurodevelopmental toxicity outcomes are presented in the study by Gilbert et al., (2013) . Results gathered from a portion of those research studies were used to create a BBDR-HPT axis model in the lactating rat and nursing pup. Data from the study by Gilbert et al., (2013) were collected during the morning hours, and other data sets used in the model development were collected during the day. This is important because the HPT axis undergoes 24-h cycles (Campos-Barros et al., 1997) , which is thought to be triggered by photoperiod (Ross et al., 2011) .
The BBDR-HPT axis model structure for the lactating dam and pup ( Fig. 1 ) consisted of a 4-compartment submodel for iodide in the dam and a 3-compartment iodide submodel in the pup. The tissue:plasma partition coefficient values were assumed to equal 1.0 for the sodium iodide symporter (NIS) protein containing tissues (thyroid gland and mammary tissue) and the body compartment. Total thyroxine (T4) and total triiodothyronine (T3) were described with a single compartment, that is, a volume of distribution, for both the dam and pup.
Five treatment groups, based on daily food consumption and the concentration of total iodide in the chow, are described in the study by Gilbert et al., (2013) . Dietary intake of iodide (µg/day) for Diet 1 (D1 = 39.4), Diet 2 (D2 = 6.4), and Diet 3 (D3 = 4.1) was considered sufficient for normal thyroid function, whereas Diet 4 (D4 = 1.2) and Diet 5 (D5 = 0.31) were insufficient FIG. 1. Schematic of BBDR model for the lactating rat and pup. Iodide (I) is ingested from chow by the dam and is excreted in urine, feces, and milk. The nursing pup ingests iodide in milk and excretes iodide in urine. Iodide distribution in the dam is described using four compartments and in the pup using three compartments. Thyroid hormones (T4 and T3) in the dam and pup are formed in the thyroid gland from thyroidal iodide stores and are secreted into the body (dotted arrows entering the dam and pup volume of distribution compartments for T4 and T3). Thyroid hormones are metabolized, releasing iodide, which is recycled in the body (solid arrows entering the iodide body compartment of the dam and pup). A small fraction of T4 is excreted in feces and milk in the dam.
for normal thyroid function. In this BBDR-HPT axis model, calibrations were carried out for each dietary iodide treatment group (D1, D2, D3, D4, and D5) to evaluate alterations in model parameter values.
The strategy for construction of the BBDR-HPT axis model for the lactating rat and rat pup, consisting of submodels for iodide, T3, and T4, was to use physiological values obtained from the literature (Table 1 ) and obtain initializing values for certain model parameters from other BBDR-HPT axis models (McLanahan et al., 2008) . Several model parameters were visually fitted (Table 2 ) using data sets from the study by Gilbert et al., (2013) and are discussed in the Results section.
For thyroid hormones, the initial conditions for T4 and T3 secretion rates from the thyroid gland and whole-body metabolic rates were set equal to values reported by Lorscheider and Reinke (1972) and Dubois and Dussault (1977) in the euthyroid lactating rat and pup. The fitted model parameter values for the D2 dietary group were used as initial conditions for evaluation of the iodidedeficient diets (D4 and D5). The fitted model parameter values are compared with the literature values in the Results section.
The lactating dam submodel for dietary iodide describes oral ingestion of iodide, its sequestration into the thyroid gland and subsequent use in thyroid hormones, its release from metabolism of thyroid hormones (deiodination), and its elimination from the body in urine, feces, and milk. The thyroidal organified iodide pool was considered to represent precursor thyroid hormones (monoiodotyrosine and diiodotyrosine) and thyroid hormones, T3 and T4, the latter of which were secreted from the thyroid gland into the body (volume of distribution). T4 was metabolized by deiodinases to T3 and iodide for recycling (1 nmol T4 → 1 nmol T3 + 1 nmol iodide). T3 was metabolized by deiodinases releasing all of its iodide for recycling (1 nmol T3 → 3 nmol iodide + 1 nmol thyronine). Additionally, a very small fraction of T4 was assumed to be excreted in milk and ingested by the pup litter. Because thyroid hormones in milk were not measured and the physiological activity of maternal thyroid hormones in nursing pups remains unclear, it was assumed that oral intake of maternal thyroid hormone (T4) by the pup was negligible and could be ignored (Karimova et al., 1983) . Deiodination was the major metabolic pathway for T4 metabolism; however, a small fraction of T4 was assumed to undergo phase II hepatic conjugation and excretion in feces (DiStefano and Sapin, 1987) .
The source of iodide for the pup was the lactating dam's milk. Iodide's fate in the pup was the same as for the dam except that transfer to the milk compartment and fecal excretion was not included. The pup litter metabolic fate of thyroid hormones was similar to the dam, excluding phase II hepatic conjugation, which was not included because of a lack of data to estimate fecal excretion of T4. Table 1 lists the literature-derived physiological model parameter values for iodide and the volume of distributions for T3 and T4. Table 2 lists the literaturederived and fitted or calibrated submodel parameter values for iodide, T4, and T3, which were determined for each of the five dietary iodide treatment groups. The BBDR-HPT axis model for the lactating rat and nursing pups was evaluated at steady-state conditions against data collected by Gilbert et al., (2013) by running simulations for 1500 h. Maternal intake of iodide was assumed to occur over a 12-h period at a constant rate into the body compartment, and intake of iodide by nursing pups was assumed to be continuous.
Calibration.
The process of calibrating model parameter values for the BBDR-HPT axis model in the lactating dam and pup is reported in the Results section for each iodide diet (D1, D2, D3, D4, and D5) and in between the dam and pup litter (Table 2 ). Key equations shown below represent both the dam and the pup litter, unless noted otherwise. The iodide tissue:serum partition coefficient values for all NIS-containing tissues and lumped compartments were assumed to be one. Iodide and the thyroid gland:
(1) Rate of change of free iodide in thyroidal capillary compartment (RTb):
where QT is the blood flow to the thyroid gland (l/h), Ca is the plasma compartment iodide concentration (nM), CvT is the concentration of iodide in the mixed venous plasma leaving the thyroid gland (nM), RNIST (nmol/h) is the NIS-mediated rate of iodide uptake into the thyroid gland (Equation 2), PAT is the permeability area diffusion clearance constant (l/h), and CT is the concentration of free iodide in the thyroid gland (nM). (2) Rate of NIS-mediated uptake of iodide into thyroid gland (RNIST):
where V max T is the maximal velocity for active transport of iodide from systemic circulation into the thyroid gland (nmol/h) and K m is the MichaelisMenten affinity constant for binding of iodide to the NIS protein (nM). (3) Rate of change of free thyroidal iodide (RTHY):
where Rbind is the rate of organification of iodide in the thyroid gland (nmol/h) and is further described below. (4) Rate of organification of iodide in the thyroid gland (Rbind):
where Cremain is the concentration of "organified iodide" available for organification in the thyroid gland (nM) and is further defined below; kbind is a second order rate constant describing the rate of organification (nM -1 h -1
) from which thyroid hormones are secreted. Vprotein is the estimated thyroid volume occupied by protein (primarily thyroglobulin, 14% of the thyroid weight (Tietge, personal communication) (L). Covalent binding of iodide (organification) (Equation 4) was adapted from an equation to describe tissue binding of manganese (Yoon et al., 2011) .
Cremain is the concentration of "organified iodide" available for organification in the thyroid gland (nmol) and is described as:
where Amaxpool is the experimentally determined thyroidal iodide pool (nmol) and Abindpool is the amount of iodide organified in the thyroid gland (nmol), which is described by taking the integral of Rbindpool (Equation 5, see below). (5) Rate of change of bound thyroidal iodide pool (organified iodide pool) in thyroid gland (Rbindpool):
where RsecT4_i (nmol/h) and RsecT3_i (nmol/h) represent loss of iodide from the organified iodide pool as secretion of thyroid hormones. RsecT4_i equals the secretion rate of T4 (RsecT4, see below) × 4, i.e., 1 nmol T4 equals 4 nmol iodide. RsecT3_i equals the secretion rate of T3 (RsecT3, see below) × 3, i.e., 1 nmol T3 equals 3 nmol iodide.
Iodide and milk:
(6) Rate of pup litter ingestion of iodide in milk (Rnurse):
where Cmilk is the concentration of iodide in the milk (nM) and PRODmilk is the milk yield ingested by the pup litter (l/h).
T4 secretion, metabolism, and excretion:
(7) Rate of change in serum T4 in the dam's volume of distribution (RT4d):
where RsecT4 is a zero order secretion rate of T4 from the dam's thyroid gland (nmol/h), RT4met is the rate of metabolism of T4 by deiodinases (nmol/h) (see below), and RT4loss is a composite loss of T4 from the dam by lactational transfer to nursing pups and by phase II conjugation and excretion in feces (nmol/h). (8) Rate of change of T4 in the pup litter's volume of distribution (RT4p):
where RsecT4 and RT4met represent similar processes as described for the dam but are pup-specific parameters. (9) Rate of T4 excretion from the dam (RT4loss; minor pathway, lactational transfer, and fecal elimination):
where two minor pathways were combined, lactational transfer and hepatic phase II conjugation and described with a first-order rate constant (T4loss, 1/h) and the amount of T4 (nmol) in its volume of distribution (AT4, nmol). (10) Rate of T4 deiodinase metabolism (RT4met; major pathway):
where T4MET is a first-order metabolic rate constant (1/h).
T3 secretion and metabolism:
(11) Rate of change of T3 in the volume of distribution (RT3):
where RsecT3 is a zero order secretion rate of T3 from the thyroid gland (nmol/h), RT4met is the rate of formation of T3 (nmol/h) from deiodinase metabolism of T4 (1 nmol of T4 = 1 nmol of T3 plus 1 nmol of iodide), and RT3met is the rate of deiodinase metabolism of T3 (nmol/h). (12) Rate of T3 deiodinase metabolism (RT3):
where T3MET is a first-order metabolic rate constant (1/h), and AT3 is the amount of T3 in the dam or pup litter volume of distribution (nmol).
Sensitivity analysis.
A local sensitivity analysis for predicting serum total T4 concentration in the dam and pup was conducted for an iodide-sufficient diet (Diet 2) and the most iodide-insufficient diet (Diet 5) by enacting script from an m file to increase each model parameter value by 0.1% for Diet 2 and decrease each model parameter by 0.001% for Diet 5. For Diet 5, changing some model parameters by 0.1% caused the simulation to halt, reflecting the strained condition of the HPT axis (discussed in Result and Discussion sections); thus, the sensitivity analysis was conducted using a small decrease in the model parameters (0.001%).
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ReSulTS
Calibration of the Iodide Submodel
The lactating dams' dietary intake of iodide ranged over two orders of magnitude, and the corresponding serum iodide levels in the dam and pup reflected this wide range of dietary iodide intake ( Table 3 ). The pup litter serum iodide levels were greater than the dam serum iodide levels, reflecting maternal NIS protein-mediated active transport of iodide from systemic circulation into the mammary tissue and milk. Dietary intake of iodide was assumed to occur at a constant rate for 12 h per 24-h period in the dam and was simulated using a pulse function. Ingestion of iodide laden milk by the suckling pup was assumed to occur continuously. The intake of dietary iodide created a cyclic pattern for dam serum iodide levels; thus, the peak and trough iodide concentrations are reported in Table 3 . This also resulted in a muted cyclic pattern for iodide serum levels in the pup and is reported as peak and trough in Table 3 . NIS protein-mediated active uptake of iodide into the thyroid gland of the dam and pup and maternal milk was described using Michaelis-Menten equations. The affinity constant, K m , was fixed, and V max TC (thyroid gland) was adjusted slightly from a value of 5738 (McLanahan et al., 2008) to 5800 nmol/h/kg 0.75 for the dam (D1, D2, and D3 diets); in the pup litter, V max TC value of 2500 nmol/h/kg 0.75 was fit to the thyroidal iodide levels for the iodide-sufficient D1, D2, and D3 diets.
There was a trend of increasing mean levels of serum TSH for dams and pups on the D4 and D5 diets even though a statistically significant increase was only observed in the D5 dams (Gilbert et al., 2013) . Thyroid gland model parameters under the control of TSH were adjusted to reflect increases in serum TSH for D4 and D5 diets. TSH-mediated increases in dam and pup litter V max TC values, for both the D4 and D5 diets were necessary, coupled with corresponding increases in thyroidal blood flow rates (QT) and the organification rates (kbindC), to simulate reduced thyroidal iodide stores in a manner consistent with the measured serum iodide concentrations (Table 3) .
That is, the thyroid gland was stimulated by TSH to maintain a reduced level of organified iodide, despite much lower serum levels of iodide.
For both iodide-deficient diets, D4 and D5, the dam and pup V max TC values of 5800 and 2500 nmol/h/kg 0.75 were increased to 20,000 and 10,000 nmol/h/kg 0.75 to predict the reduced thyroidal iodide stores, given the low serum iodide levels. Also the blood flows to the thyroid glands of the dam and pups (QT) were increased by 1.5-fold for the D4 dams and pups and by threefold for the dams and pups in the D5 group (Table 1) . Corresponding to thyroidal NIS stimulation by TSH, the rate of organification (kbindC, 1/[nmol/h/kg 0.75 ]) was increased by 20-fold in the dam and 3.3-fold in the pup for the D4 and D5 diets. KbindC and V max TC values for the dam and pup that were fitted to maintain the thyroidal iodide stores for the D5 diet were also sufficient to describe thyroidal iodide stores for the D4 diet.
A V max MC value (Table 2 ) of 640 nmol/h/kg 0.75 , describing the uptake of iodide into milk, was visually fit in an iterative fashion to describe serum iodide levels in the pup for the D1, D2, and D3 control diets and then later found to be sufficient for the iodide-deficient diets, D4 and D5. The NIS protein in the mammary tissue was considered to be resistant to stimulation by TSH.
A bisymmetric diffusion clearance constant value for iodide and the thyroid gland (PATC) was raised from a reported value of 0.0001 l/h/kg 0.75 for the dam (McLanahan et al., 2008) and pup to a value of 0.001 l/h/kg 0.75 for both the dam and pup. PAMC, the bisymmetric diffusion clearance value for the mammary tissue/milk and iodide, was decreased from a reported value of 0.02 ) were adjusted slightly up or down from the initial value of 0.0047 l/h/ kg 0.75 (McLanahan et al., 2008) to fit the serum level of iodide in the dam and pup for each diet (Table 2) . CLUC values varied Note. MP serum iodide levels reflect the peak and trough cycle that occurred after ingestion of iodide.
by less than twofold across all diets. No trend was observed between the fitted CLUC values and dietary iodide intake. A small amount of iodide was assumed to be excreted in the dam feces (Visser et al., 1993) , which in this case was predicted to range from about 0.4 to 1% of the daily intake of iodide for the iodide-sufficient diets (D1,D2, and D3) and under 0.01% for iodide-deficient conditions (D4 and D5).
Comparison of Iodide Submodel Predictions and Observations
As would be expected for model predictions based on using the same data as used to calibrate the model, the predicted serum iodide level ranges (peak and trough) for each iodide diet were consistent with observations for the dam and pup (Table 3 ). The measured thyroidal iodide pools (organified iodide) for the dam and pup for each iodide diet were reproduced by model simulations (Fig. 3) .
Calibration of the Thyroid Hormone Submodels
To fit the dam serum T4 levels (Fig. 2) , the thyroid T4 secretion rate (RsecT4, nmol/h) was set to 0.161 nmol/h for the euthyroid diets D1, D2, and D3, which was equivalent to a secretion rate of 3 µg/day based on lactating euthyroid rats (Lorscheider and Reineke,1972) . For iodide-deficient diets, D4 and D5, RsecT4 was fitted to serum T4 levels (while maintaining thyroidal iodide stores) by slightly decreasing RsecT4 values. RsecT4 was set to 0.13 nmol/h (2.42 µg T4/day) for the D4 diet and 0.07 nmol/h (1.33 µg T4/day) for the D5 diet.
Decreases in T4 production rate are consistent with reports by Lorscheider and Reineke (1972) for iodide-deficient diets.
In the pup, secretion of T4 (RsecT4) increases after birth, peaks at PND 14, and then decreases (Dubois and Dussault, 1977) . Dubois and Dussault (1977) estimated the T4 secretion rate for an individual euthyroid PND 14 pup at 0.0332 nmol/h (0.62 µg T4/day). Fitted euthyroid RsecT4 rate for the pup in the D1 group was 0.04 nmol/h (0.75 µg T4/day); for pup from the D2 and D3 groups, RsecT4 was 0.025 nmol/h (0.46 µg T4/ day). In iodide-deficient diets, the D4 RsecT4 was reduced to a value of 0.010 nmol/h (0.186 µg T4/day) and for D5 pups, 0.0047 nmol/h (0.087 µg T4/day). With a litter size of 10 pups, pup RsecT4 rates were increased by 10-fold for simulation purposes ( Table 2) .
Metabolism of T4 (T4METC, /h/kg 0.75 ) in lactating dams was described with a scaled first-order term. Dubois and Dussault (1977) reported a first-order adult rat systemic elimination rate constant of 0.041/h per rat for metabolism of T4. This metabolism term equates to a scaled first-order term of 0.104/h/kg 0.75 and was used for all dietary iodide treatment groups, except for the lowest dietary iodide intake, D5. For the D5 group, the metabolic rate was slightly reduced to a value of 0.08 /h/kg 0.75 (~0.032/h) to describe the serum T4 concentrations at steady state (Fig. 4) .
First-order systemic elimination constant values used to describe metabolism of T4 in euthyroid individual pups were fairly constant across ages (Dubois and Dussault, 1977) and for PND14 pups reported equal to 0.057/h by Dubois and Dussault (1977) . The fitted scaled first-order metabolic rate 
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constant (T4METC) for the D1 group was 0.2/h/kg 0.75 , and for D2 and D3 dietary iodide groups, T4METC was 0.13/h/kg 0.75 . The T4 metabolic rate for an individual pup in the iodidesufficient group D1 was greater (~0.09/h) than the value reported by Dubois and Dussault (1977) (0.057/h), whereas in the iodide-sufficient groups, D2 and D3, the T4 metabolic rate was similar (~0.06/h). Metabolic rate constants for iodide deficiency groups, D4 and D5, were decreased to 0.069/h/kg 0.75 , which equated to a first-order metabolic rate of ~0.03/h. Thyroidal T3 production in euthyroid dams was reported to be 27% of the T4 thyroidal production rates (Dubois and Dussault, 1977) . However, after several attempts to simultaneously describe thyroidal iodide stores and serum T3 and T4 concentrations, the thyroidal T3 production rate in dams (RsecT3) was reduced for all treatment groups to 10% of the T4 thyroidal production rate (RsecT4) for euthyroid rats (0.016 nmol/h). Thus, for the iodide-deficient D4 and D5 groups, with reduced T4 thyroid secretion rates, the proportions of T3 thyroidal secretion were increased to 12 and 23%, respectively, of the T4 thyroidal secretion rates. Because enzymatic conversion of T4 to T3 in the body creates a large pool of T3, it is difficult experimentally to segregate thyroidal derived T3 from T3 formed from extrathyroidal conversion of T4 to T3. In addition, reverse T3 formed by Type III deiodinase was not accounted for in the model probably resulting in a modest underestimate of T3 thyroidal secretion.
Excretion of T4 in feces (McLanahan et al., 2008) as a conjugate or in milk (Karimova et al., 1983 ) was assumed to represent approximately 5% of the amount of T4 secreted from the thyroid gland for the control diets but dropped to under 0.01% of the T4 secreted for iodide-deficient conditions. Dubois and Dussault (1977) reported euthyroid PND 14 pup thyroidal T3 secretion rate equal to 8% of the thyroidal T4 secretion rate. Fitted T3 pup litter secretion rates (RT3sec) were fitted to serum T3 levels and pup litter thyroidal iodide stores (Fig. 5) . In this case, the calibrated model-predicted individual pup T3 secretion rate was 9% of the thyroidal T4 secretion rate (RsecT4) for iodide-sufficient D1 treated pup and 14% for the iodide-sufficient D2 and D3 pups. For iodide-deficient diets, the T3 secretion rate was 36% of the T4 secretion rate for D4, but for the most iodide-deficient diet, D5, T3 secretion rate was only 9% of the T4 secretion rate. Differences in the degree of iodide deficiency between the D4 and D5 groups may be responsible for this apparent dichotomy in T3 secretion rates for iodide-deficient pups. Dubois and Dussault (1977) reported an adult rat first-order metabolic term for systemic T3 of 0.08/h. The scaled first-order metabolic rate constants for metabolism of T3 in the D1, D2, D3, and D4 lactating dam (T3metC, /h/kg 0.75 ) were fitted and because of a similar outcome set to a single value of 0.35/h/ kg 0.75 , which equates to ~0.14/h for the dam. T3 metabolism in D5 dam was reduced to a value of 0.20/h/kg 0.75 or ~0.08/h in order to describe the systemic concentration of T3.
The scaled first-order metabolic rate for metabolism of T3 in the pup litter (T3METC) was fitted to a value of 0.9/h/kg 0.75 for the euthyroid iodide groups (D1, D2, and D3) and for the iodidedeficient group D4. T3METC was lowered to a value of 0.3/h/ kg 0.75 for D5 iodide-deficient group. Dubois and Dussault (1977) reported a first-order metabolic rate for T3 equal to 0.08/h for the PND 14 rat pup. In this study, the individual pup metabolic rates were ~0.4/h for the D1 through D4 iodide diets and ~0.1/h for the D5 iodide-deficient pup. The reason for the discrepancy between this study and Dubois and Dussault (1977) is unknown.
Comparison of Thyroid Hormone Submodel Predictions and Observations
Serum T4 levels were not altered for iodide-sufficient rats (D1, D2, and D3), whereas iodide-deficient conditions (D4 and D5) resulted in decreased mean serum T4 levels, with statistical significant changes reached only in D5 group (Gilbert et al., 2013) . Model predictions, calibrated to each diet, agreed with observations for both the dam and pup (Fig. 4) . Serum T3 levels were not altered in any of the iodide diet groups, and model predictions were in agreement with this observation for the dams and pups (Fig. 5) .
HPT Axis Evaluation for Dietary Iodide
For nursing pups, the calibrated BBDR-HPT axis model for each dietary iodide treatment predicted that a large fraction of the ingested iodide in milk was excreted in urine each day, if expressed as percent of daily dietary iodide intake (> 95%), whereas in the dam, iodide excretion was divided between transfer to the milk and nursing pup litter (30-60%) and the remainder in urine.
Iodide produced from metabolism of thyroid hormones and their breakdown products was very important for maintaining the HPT axis. The model-predicted amount of iodide produced from enzymatic deiodination in the lactating dam was 15-16 nmol/day for the iodide-sufficient groups (D1, D2, and D3) and was decreased to 13.4 and 7.7 nmol/day in dietary iodide-deficient treatments, D4 and D5, respectively. When the model-predicted dietary iodide intake per day was summed with model-predicted iodide produced from thyroid hormone deiodinase metabolism per day (total available iodide/day), the fraction of total daily iodide derived from thyroid hormones was estimated to be 75% for the D5 and 60% for D4 iodidedeficient diets. In the iodide-sufficient groups, D2 and D3, the percentages of total available iodide derived from thyroid hormone metabolism were less (24 and 33%), and for the D1 diet, thyroid hormone production only accounted for 5% of the total available daily iodide.
The model-predicted daily intake of iodide per pup from nursing was estimated to be 12.7, 3.0, and 1.4 nmol/day for the iodide-sufficient diets, D1, D2, and D3, respectively. For individual pups from D4 and D5 iodide-deficient diets, the intake of iodide from nursing was reduced to 0.28 and 0.11 nmol/day. For control diets, the individual pup model predicted amount of iodide produced from metabolism of thyroid hormones ranged from 2.6 nmol/day for D2 and D3 diets to 4 nmol/day for the D1 diet. For iodide-deficient diets, D4 and D5, the thyroid hormone-derived iodide production rates were 1.2 and 0.5 nmol/ day for the individual pup. The fraction of total available iodide/ day contributed by thyroid hormone metabolism in the pup was estimated to be 25, 47, and 65% for the iodide-sufficient diets, D1, D2, and D3, respectively, and 80 and 81% for the iodidedeficient diets, D4 and D5.
Sensitivity Analysis
Body weight (BW) of the dam and pup was the most sensitive model parameter for both iodide-sufficient (D2) and iodide-deficient diets (D5). See Materials and Methods section for the rationale of using a 0.1% change for the D2 diet and a 0.001% change for the D5 diet. A 0.1% increase in BW for the dam and pup for Diet 2 caused a 0.175% decrease in serum T4 levels in the dam and pup. A similar but inverted pattern occurred for the Diet 5, where a 0.001% decrease in BW for the dam and pup resulted in a 0.00175% increase in serum T4 levels in the dam and pup. Other model parameters that directly contribute to the calculation of serum T4 concentrations were sensitive in the dam and pup for both dietary iodide diets. The secretion rate of T4 from the thyroid gland (RsecT4), the rate of metabolism (deiodination) of T4 (T4METC), and the volume of distribution for T4 (VDT4) in the dam and pup were sensitive to predicting serum T4 concentrations for both dietary iodide diets. Increasing each of these parameter values in Diet 2 by 0.1% resulted in a corresponding decrease of 0.1% in serum T4 concentrations. For Diet 5, serum T4 concentrations increased 0.001% with a 0.001% decrease in value of each of these model parameter values. All other model parameter values were insensitive to the prediction of serum T4 concentrations in the dam and pup.
DISCuSSIon
The objective of this BBDR model for the HPT axis was to calibrate each dietary iodide group to describe the serum T3 and T4 concentrations and thyroidal iodide stores (organified iodide) using dietary intake data calculated from food consumption. As the model calibration progressed from iodidesufficient dietary conditions (D1, D2, and D3) to iodidedeficient conditions (D4, D5), changes in euthyroid model parameters were required to describe these data (Gilbert et al., 2013) . Not surprisingly, D5, the most iodide-deficient group, displayed the greatest perturbations in the HPT axis (Tables 2 and 3 ). When dietary iodide intake was estimated to be 0.3 µg per day, the thyroidal iodide stores were reduced by almost an order of magnitude in the dam and pup, and serum T4 concentrations were reduced by nearly 50% in both the dam and pup, whereas serum T3 concentrations were maintained. Mean serum TSH levels were modestly elevated (Gilbert et al., 2013) .
To predict these HPT axis changes in the D5 group, several model parameters were changed, including increasing blood flow to the thyroid gland and TSH-mediated increase in thyroidal uptake of iodide and its organification. Increases in thyroid blood flow reaching 350% of control euthyroid values have been reported in the iodide-deficient rat (less than 1 µg iodide intake per day) and decreases up to 54% with rats administered excess iodide (500 µg iodide intake per day) (Michalkiewicz et al., 1989) . Interestingly, the increased blood flow and vascularization of the thyroid gland appear to be controlled independently of TSH (Michalkiewicz et al., 1989) . TSH-induced increases in NIS transport of iodide into the thyroid gland and its subsequent organification have been described in BBDR-HPT axis models previously for iodide deficiency (McLanahan et al., 2008; Gilbert et al., 2011) and with perchlorate-induced hypothyroidism in the adult rat (McLanahan et al., 2009) .
In the most iodide-deficient group D5, simulations consisted of TSH-mediated stimulation of the thyroidal NIS protein (V max TC) by 3.4-fold in the dam and 4-fold in the pup and increased binding constant for organification (kbindC) for the dam (20-fold) and pup (3.3-fold). These parameter adjustments in the model were necessary to simulate the observed thyroidal iodide stores. For the D5 iodide-deficient group, thyroidal secretion rates of T4 were decreased in the dam and pup (57 and 81%, respectively), whereas T3 thyroidal secretion rate was assumed not to change in the dam but was reduced by 90% in the pup. The fractional yield of thyroidal T3 increased (as a percent of T4 hormone secretion) in the dam and in the pup, despite an apparent drop in T3 secretion from the pup thyroid gland. Metabolism BBDR MODEL FOR HPT AXIS IN LACTATING RAT of T4 was also decreased by 24 and 47% in the dam and pup, respectively, and T3 metabolism similarly decreased by 43 and 67%. The changes in pup model parameters to describe the experimental data suggest that the pup was less resilient to this insufficient iodide diet than was the dam. The end result of these changes in model parameters to describe the serum levels of thyroid hormones is that the measured ratio of serum T3 to serum T4 increases with decreasing intake of iodide in the pup as reported by Gilbert et al., (2013) ; Table 2 .
The impact of the D4 iodide-insufficient diet on the HPT axis was more modest than that of D5 diet in the dam. T4 thyroidal production was decreased 19% in the dam, whereas there was no apparent change in the T4 metabolic rate. In the pup, T4 production was reduced by 60%, and the T3 metabolic rate decreased by 47%. The stimulation of the NIS-mediated thyroidal uptake of iodide and organification was assumed to be similar in the D4 and D5 diets primarily because of a lack of experimental data on the iodide dose-dependent changes in the NIS protein. In the high dietary iodide diet, D1, the only obvious adaptation compared with the D2 and D3 iodide-sufficient groups was that the T4 secretion rate was increased in the pup. Perhaps, the pup homeostatic controls of the HPT axis are not as robust as the adult rat; thus, excess iodide results in increased thyroid organification and secretion of T4.
Mechanistic Insights
The robustness of the HPT axis is remarkable, with an ability to function over a wide range of dietary iodide intakes. However, clear dose-dependent changes in the HPT axis were observed in the iodide-deficient diets (D4 and D5). Even with induction of compensatory mechanisms, such as TSH stimulation of the thyroid gland, the consequences of iodide insufficiency could not be overcome to re-establish euthyroid conditions. Reduced thyroid hormone production is a direct result of less thyroidal organified iodide stores, whereas downregulation of T4 and T3 metabolism is probably controlled by reduced Type I and III deiodinase activities in organs such as the liver and kidney. Type I and II deiodinase enzymes convert T4 to T3, and Type III deiodinase enzyme converts T4 to an inactive form of T3, reverse T3 (rT3). The ability to maintain serum T3 levels under the conditions of this study, despite decreases in organified iodide stores and serum T4 levels, suggests that compensatory mechanisms, i.e., increased thyroidal secretion rate of T3 relative to T4, are important for the dam and pup. Lorscheider and Reineke (1972) evaluated iodide-deficient conditions in the lactating dam and nonlactating Sprague Dawley rats. The rats were placed on either of two iodide-deficient diets or one iodide-sufficient diet. The thyroxine secretion rate from the thyroid gland and metabolic rates were determined by "whole-body" kinetic analyses. Also thyroidal iodide stores were reported. In agreement with our model predictions, the authors reported that iodide deficiency reduced the production and metabolic rate of T4 and reduced thyroidal iodide stores. Other iodide-deficient studies in the rat pup (Dussault and Walker, 1978; Escobar del Rey et al., 1987) reported reductions in serum thyroid hormone concentrations, increases in serum TSH concentrations, and reductions in thyroidal iodide stores, which are associated with reduced thyroid hormone concentrations in the brain (Escobar del Rey et al., 1987) . Dussault and Walker (1978) reported on serum thyroid hormone and TSH concentrations in serum in iodide-deficient rats of ages PND 1 to 57. In the case of the PND 18 rat pup, serum T4 levels were reduced by twofold, serum T3 levels were increased by twofold, and serum TSH levels were elevated approximately sixfold, indicating more severe iodide deficiency than occurred in this study. Nevertheless, the study results of Dussault and Walker (1978) are consistent with the findings of Gilbert et al., (2013) .
Controversy exists surrounding the interpretation of serum thyroid hormone levels because these systemic measurements may not reflect the thyroid hormone status in critical tissues. The cellular fate of thyroid hormones is important and complicated, and there is considerable uncertainty in relating change in serum thyroid hormones with neurodevelopmental outcomes. In the Gilbert et al., (2013) study, from which the data sets were used to calibrate the BBDR-HPT axis model, the PND14 pups did not show changes in T4 cortex concentrations in response to the iodide-deficient diets, despite reduced serum T4 levels caused by the D5 iodide diet. However, this was not the case in utero where decreases in fetal serum T4 coincided with reductions in fetal cortical levels of T4 on GD16 and GD20 (Gilbert et al., 2013) . Thus, it appears that the window of susceptibility for iodide deficiency is during fetal development, and the serum T4 dosimetrics modeled in the PND14 pups are associated with neurodevelopmental outcomes that probably occurred in utero.
Thyroid hormone transporters transfer thyroid hormones across the plasma membrane into tissues. Metabolism of thyroid hormones within cells of tissues or organs is complicated because there are three forms of a deiodinase enzyme (Type I, II, and III) that are also regulated by thyroid hormones, and their induction or suppression is organ specific and within an organ like the brain, region specific. Biomarkers of signaling pathways and further studies demonstrating dose-dependent differential organ pathological changes, mediated by modest thyroid hormone insufficiency, are needed to further develop and refine BBDR HPT axis models.
Model Strengths and Weaknesses
The BBDR-HPT axis model was calibrated using key data sets collected from a single research program, which is favorable over gathering data from many diverse experiments spanning 3-4 decades. The study of Gilbert et al., (2013) used several doses of iodide intake, and in terms of serum thyroid hormone perturbations, only modest effects were observed. These data, coupled with information from the literature and previous modeling efforts, allowed for an informative quantitative analysis of the HPT axis in response to iodide deficiency in the lactating dam and pup. Some aspects of the model calibration were easier than others. For example, model development and calibration for the dam were generally easier than for the pups, and calibrating the T4 submodel was easier than the T3 submodel. Calibration of the model for the lowest intake of dietary iodide was more difficult than iodide-sufficient diets because modest changes in model parameters would result in failure to describe the HPT axis. This suggests that under these conditions thyroid-active chemicals or drugs may exacerbate the functional status of the HPT axis. The sensitivity analysis revealed that the scaled model parameters used to calculate T4 serum levels were sensitive in predicting serum T4 levels. Conducting new studies on the kinetics of T4 and T3 in different life stages would be useful as part of a strategy to address life stages and the HPT axis. Several compensatory mechanisms may underlie the observed alterations in the HPT axis and are represented by changes in specific model parameter values. For example, hypothyroidism decreases plasma membrane transport of thyroid hormones into adipocytes (Richie et al., 2001) , whereas in the brain, hypothyroidism leads to upregulation of Oatp14 expression (Sugiyama et al., 2003) . These changes may affect the apparent volume of distribution for thyroid hormones. Thus, thyroid hormone production or metabolic rates, e.g., may be less affected than reported in this model analysis. A more mechanistic approach is desirable to describe intracellular levels of thyroid hormones, both in the thyroid gland and in organs or regions within organs along with biomarkers of thyroid hormone action on transcription using a single calibrated BBDR model. The model would include TSH, reverse T3, and organ-specific type I, II, and III metabolic rates for metabolism of thyroid hormones for a range of iodide intake spanning iodide deficiency to sufficiency. Additionally, neurodevelopmental toxicity studies are required to construct dose-response curves relating HPT status with pathological changes. Currently, a BBDR model that describes the maturation of the HPT axis in the euthyroid fetus and pup is lacking and represents an ongoing effort in our laboratory. Developing a BBDR HPT axis model for the pregnant rat and fetus, using data sets in Gilbert et al., (2013) with those of Escobar del Rey (1987) and Versloot et al., (1997) , is important because the likely window of susceptibility for neurodevelopmental responses to iodide deficiency occurs during this life stage.
With the continued growth of computational tools in toxicology, quantitative descriptions of signaling pathways, such as those involved in the HPT axis, will be forthcoming. Incorporation of such information in a BBDR framework will provide a more accurate depiction of the HPT axis signaling pathways and a higher fidelity model to represent this complex biological system.
Dose-Response Assessment of Iodide Deficiency
A description of changes in serum thyroid hormones is pivotal in extrapolating effects observed in animals to humans because this is a widely used biomarker of HPT axis status. Model-predicted average daily area-under-the-serumconcentration-curve (AUC, nM/day) values for T4 at steady state in the dam and pup were 932 and 105 for the 1.2 µg/ day (D4) diet, and 539 and 71.6 for the 0.31 µg/day (D5) diet, respectively. This is comparable with iodide-sufficient diets of 6.4 and 4.1 µg/day (D2 and D3) with AUC ranges of 1086-1104 for the dam and 125-123 nM-day for the pup. The decrease in daily AUC values for serum T4 was only 14-15% for the PND 14 pup and dam that are associated with persistent synaptic impairment in the brain of the adult offspring (Gilbert et al., 2013) . These pups were born to dams fed iodide-deficient diets prior to breeding and throughout gestation and lactation. As such a BBDR-HPT axis model for the lactating dam and nursing pup is useful in predicting alterations in the HPT axis caused by iodide deficiency and with modifications, this model could be extended to study thyroidactive chemicals or drugs that do not act on the thyroid gland by blocking uptake of iodide. Furthermore, extending the model in both directions, upstream to describe cellular and molecular events associated with thyroid hormone status and downstream to tie alterations in HPT axis status to disruptions in brain developmental processes, would greatly reduce the uncertainty in using serum thyroid hormone levels as a proxy for HPT axis-induced developmental neurotoxicity. 
